Our data indicated the increased S100A8 and S100A9 were associated with increased IFN-γ and TGF-β but decreased IL-10 in clinical and animal models of EACC, consistent with the pathogenesis mechanism of inflammation involved in cholesteatoma pathogenesis. Here, S100A9 is linked to cholesteatoma.